September 22, 2023 Comments for Annex XV Restriction Report on the Manufacture, Placing on the Market and Use of PFASs; Evidence for Question 3: Emission in the EndofLife Phase.
refid# Rjaxd6VNZjB8dDL1ZE7eXG90V2 pages
4th submission - Comments on the proposed restriction of universal PFAS September 22, 2023 Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.
refid# MJb1qaaE1Koy9eGX5MGe4gJbz8 pages
Comments on EU PFAS Restriction Proposal June 5, 2023 Japan Chemical Industry Association (JCIA) appreciates the opportunity to provide the following comments in response to the proposal of this PFAS restriction.
refid# J3kBR47eJxjmV8DDdjjoMxJwO5 pages
PFC's analyses.
refid# mKz6wqmyOpemByyjB950m3aQ2 pages
FINAL REPORT Hydrothermal Technologies for On-Site Destruction of Site Investigation Wastes Contaminated with Per- and Polyfluoroalkyl Substances (PFAS) SERDP Project ER18-1501 SEPTEMBER 2020 Timothy J.
refid# 1gOamgxze7B9rQvLmbX5gp3kE89 pages
Draft agenda for PFAS-RESTRICTION WEBEX Meeting between DE, DK, NL, NO, SE CA and ECHA 28 September 2020, 9:00 - 13:00 (CET) Login details: See below Point 1 - Opening and adoption of the agenda (9:00-9:10) Point 2 - Minutes and action points (9:10 - 9:20) 2020-09-10_PFAS RESTR-8 Minutes and APs_Draft of FINAL.docx 2020-09-22_Continued list of APs and their status.docx Point 3 - Update Commission/ECHA (9:20 - 9:30) Firefighting foams Point 4 - OECD work on PFAS (9:30 - 10:00) Presentation by Point 5 - Status update WP1 (10:00 - 10:30) RMOA Discussion on timeline for draft RMOA template 2020-09-21_PFAS_RMOA_Template_DE_NL Call for evidence Stakeholder meetings on general topics Point 6 - Status update WP4 (10:30 - 11:00) All Member States to give an update on their work on the different sub-uses WP7 contribution to WP4 activities Overview coordination stakeholder contacts Outstanding issues Break 11:00 - 11:30 Point 7 - Status update WP2 (11:30 - 12:00) 2020-08-30 PFAS scope discussion document and meeting 21-09-2020 Point 8 - Status update WP3 (12:00 - 12:15) Point 9 - Status update WP7 (12:15 - 12:30) Update discussion document and next planning Point 10 - Preparation RiME+, 21/22 okt (12:30 - 12:45) Draft presentation Questions for feedback MS 2020-09-21_RiME_PFAS_RESTR_MSCAs Point 11 - Communication (media, parliament) (12:45 - 12:55) Point 12- Action points, next steps & meetings (12:55 - 13:00) Next WebEx meeting: October 26 ECHA Risk Management invites you to join this Webex meeting.
refid# KGB5n3NDzo6pjx6Ldag0vbeEK3 pages
I PAC International Pharmaceutical Aerosol Consortium ipacinhaler.org I February 2022 IPAC Member Survey on European Manufacture and Export of HFC MD's - Sharing Insights IPAC HFC MDI Survey -- Background and Methods In 4Q 2021, the International Pharmaceutical Aerosol Consortium (IPAC) conducted a survey of its member companies regarding the manufacture of HFC MDIs in the European Union, including volumes imported and exported.
refid# qkveGGa3j5qea5QNn6bJ7REkG1 page
Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.
refid# eD5B7r4b8D8ebXgJgnQe63G49 pages
June 8,2023 JAPAN CONSTRUCTION EQUIPMENT MANUFACTURERS ASSOCIATION 2F, Kikaishinkokaikan 3-5-8 Shibakoen, Minato-ku, Tokyo 105-0011, Japan TEL(03)5405-2288/FAX(03)5405-2280 Written comments on the Annex XV Restriction Report Restrictions on the manufacture, market placement, and use of PFAS, jointly proposed by Germany, the Netherlands, Sweden, Norway, and Denmark, have been published in the Annex XV Restriction Report.
refid# 65OONpYywRBgwBrYy7E0zjmQo8 pages
Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.
refid# YG8wjzJknOxMZx56D9vkEMwJK9 pages
VALQUA Group Sustainability Report 2022(extract) VALQUA with Society VALQUA's Relationship to Society Our "products & services" play an active role in all sorts of places. : Products containing PFAS N Medical institutions Fluorocarbon resin skived tape These products use advanced technology to cut fluorocarbon resin.
refid# 88wmBdypk9B8YMmQx7DEZw5K1 page
Comment on Proposed Restriction of PFAS May 30, 2023 Japan Fluoropolymers Industry Association (JFIA) We, Japan Fluoropolymers Industry Association (JFIA), think that fluoropolymers should be distinguished from the proposed restriction of PFAS (Per- and polyfluoroalkyl substances), which collectively regulates more than 10,000 of organofluorine compounds (PFAS) on the grouping basis.
refid# LJnKLBM99kYadLE6zNwRR6o3X12 pages
EPTA position regarding the proposal to restrict per- and fluoroalkyl substances (PFAS) under REACH and application for derogation 1.
refid# RzVnw3ZBmDowB9wweyybeMwa9 pages
Comment on Proposed Restriction of PFAS Jul 31, 2023 Japan Valve Manufacturers' Association (JVMA) Japan Valve Manufacturers Association (JVMA) appreciates the opportunity to provide comments to the PFAS restriction proposal. 1.
refid# YXJD0X1Dx52b2gD6602k3b8K2 pages
iScience Cellpress OPEN ACCESS ArticIr Implications of PFAS definitions using fluorinated pharmaceuticals Organofluorine Pharmaceuticals (360) Fluoxetine (Prozac) Sitagliptin (Januvia) Atorvastatin (Lipitor) Ciprofloxacin (Cipro) Fluticasone Propionate (Flonase) Screening Against 9 PFAS Definitions Chemical Substructures F F F Emily Hammel, Thomas F.
refid# VJeqL7g3JLXJYa2kyaKqdk7xg16 pages